Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Study of NINLARO® in Chinese Adults With Multiple Myeloma
ClinicalTrials.gov study NCT05013190. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01698801. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02597062. IPD Sharing: NO. Countries: 1. Publications: 2.
Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
ClinicalTrials.gov study NCT02780609. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma
ClinicalTrials.gov study NCT02654990. IPD Sharing: Not stated. Countries: 22. Publications: 1.
Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
ClinicalTrials.gov study NCT00322842. IPD Sharing: Not stated. Countries: 1. Publications: 3.
MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma
ClinicalTrials.gov study NCT04552743. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01564537. IPD Sharing: Not stated. Countries: 2. Publications: 8.
P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)
ClinicalTrials.gov study NCT03288493. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab
ClinicalTrials.gov study NCT03871829. IPD Sharing: YES. Countries: 13. Publications: 1.
Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT02916771. IPD Sharing: NO. Countries: 1. Publications: 2.
S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma
ClinicalTrials.gov study NCT00064038. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02661022. IPD Sharing: Not stated. Countries: 1. Publications: 35.
Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma
ClinicalTrials.gov study NCT00287872. IPD Sharing: Not stated. Countries: 1. Publications: 1.
MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT04555551. IPD Sharing: YES. Countries: 1. Publications: 2.
UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00580372. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)
ClinicalTrials.gov study NCT02654132. IPD Sharing: Not stated. Countries: 11. Publications: 2.
CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
ClinicalTrials.gov study NCT01995708. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02186834. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01160484. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.